Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 19 of about 19 for Gary Lyons
Company Exchange Symbol Last price Quote change Market cap
Baldwin & Lyons Inc NASDAQ BWINB 26.03 -0.18 (-0.69%) 389.98M
Baldwin & Lyons, Inc., through its divisions and subsidiaries, is engaged in marketing and underwriting property and casualty insurance and the assumption ...
Executive:
Gary Wayne Miller
William Lyon Homes NYSE WLH 26.32 -0.21 (-0.79%) 816.73M
William Lyon Homes is primarily engaged in the design, construction and sale of single family detached and attached homes in California, Arizona and Nevada.
Executive:
Gary H. Hunt
William Lyon Homes Inc Private
William Lyon Homes, Inc. is primarily engaged in the design, construction and sale of single-family detached and attached homes in California, ...
Executive:
Gary H. Hunt
Baldwin & Lyons Inc NASDAQ BWINA 23.77 -0.20 (-0.84%) 386.80M
Baldwin & Lyons, Inc., through its divisions and subsidiaries, is engaged in marketing and underwriting property and casualty insurance and the assumption ...
Executive:
Gary Wayne Miller
Cytori Therapeutics Inc. (USA) NASDAQ CYTX 2.49 -0.12 (-4.60%) 187.87M
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose- derived stem and regenerative cells (ADRCs) to treat cardiovascular disease ...
Executive:
Gary A. Lyons
Neurocrine Biosciences, Inc. NASDAQ NBIX 13.78 -1.02 (-6.89%) 1.05B
Neurocrine Biosciences, Inc. (Neurocrine) discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and ...
Executive:
Gary A. Lyons
Vical Incorporated NASDAQ VICL 1.21 -0.06 (-4.72%) 105.05M
Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and ...
Executive:
Gary A. Lyons
Rigel Pharmaceuticals, Inc. NASDAQ RIGL 3.21 -0.21 (-6.14%) 280.98M
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of ...
Executive:
Gary A. Lyons
Essex Property Trust Inc NYSE ESS 168.79 -1.60 (-0.94%) 6.52B
Essex Property Trust, Inc. (Essex) operates as a self-administered and self- managed real estate investment trust (REIT). The Company is engaged primarily in ...
Executive:
Gary P. Martin
Endologix, Inc. NASDAQ ELGX 12.03 -0.52 (-4.14%) 770.09M
Endologix, Inc. (Endologix) is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders.
Executive:
Gary I. Sorsher
International Frontier Resources Corp. CVE IFR 0.0900 0.0000 (0.00%) 5.72M
International Frontier Resources Corporation (Frontier) is engaged in the exploration for and development of oil and gas reserves.
Executive:
Gary McInnis
CSP Inc. NASDAQ CSPI 7.66 +0.01 (0.13%) 27.37M
CSP Inc. (CSPI) along with its subsidiaries develops and markets information technology (IT) integration solutions and high-performance cluster computer ...
Executive:
Gary W. Levine
KaloBios Pharmaceuticals Inc NASDAQ KBIO 2.40 -0.22 (-8.40%) 79.16M
KaloBios Pharmaceuticals, Inc., is a United States-based company, which develops protein therapeutics. The Company develops and engineers antibodies and ...
Executive:
Gary A. Lyons
Essex Property Trust Inc OTCMKTS ESSFP 24.00 6.18B
Essex Property Trust, Inc. (Essex) operates as a self-administered and self- managed real estate investment trust (REIT). The Company is engaged primarily in ...
Executive:
Gary P. Martin
Ridley Corporation Ltd ASX RIC 0.855 0.000 (0.00%) 263.18M
Ridley Corporation Limited is engaged in the production and marketing of stockfeed and animal feed supplements and the production of crude salt, ...
Executive:
Gary Hilton Weiss
GWR Group Ltd ASX GWR 0.150 0.000 (0.00%) 36.03M
GWR Group Limited, formerly Golden West Resources Limited, is engaged in evaluation and exploration of its mining projects in Australia.
Executive:
Gary Lyons
Peoples Bancorp Inc (Maryland) OTCMKTS PEBC 13.50 0.00 (0.00%) 10.52M
Peoples Bancorp, Inc. is a financial holding company. The Company serves as the parent company to The Peoples Bank (the Bank) and Fleetwood, Athey, ...
Executive:
Gary B. Fellows
Cytori Therapeutics Inc. FRA XMPA 1.90 +0.20 (12.00%) 128.08M
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose- derived stem and regenerative cells (ADRCs) to treat cardiovascular disease ...
Executive:
Gary A. Lyons
Cytori Therapeutics Inc. ETR XMPA 0.0000
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose- derived stem and regenerative cells (ADRCs) to treat cardiovascular disease ...
Executive:
Gary A. Lyons